Pat has many years of experience in both preclinical and clinical pharmacology. She focuses on safe and efficacious treatments for blinding eye diseases. Pat is a founding member of EyeRx Research Inc where she has teamed with ophthalmologists and other scientists and developed several ophthalmic drugs through to clinical trials and the FDA regulatory process. Pat's team has been awarded seven patents.
Pat is author of over 50 publications and a frequent guest speaker at national and international conferences. She serves as a consultant to the FDA, NASA, the pharmaceutical industry and the NIH to evaluate proposals for NIH funding. Pat graduated from the University of Michigan with a B.S. in pharmacy and with a Ph.D. in pharmacology from the Medical College of Virginia, Virginia Commonwealth University. |